These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 24495688)

  • 21. [Study on the relationship between microsatellite alterations of RASSF1A gene and the development of cervical carcinoma].
    Zhao FX; Yan J; Liu RH; Wang XY; Liu LH
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2008 Oct; 22(5):345-7. PubMed ID: 19469170
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Promoter methylation of DAPK1, RAR-β and MGMT in exfoliated cervical cytology and its clinical application].
    Zhong ZJ; Yang JX; Cao DY; Sun Y; Sun LL; Cheng XM; Chen J; Lang JH; Shen K
    Zhonghua Fu Chan Ke Za Zhi; 2012 Mar; 47(3):196-200. PubMed ID: 22781071
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Quantitative detection of RASSF1A DNA promoter methylation in tumors and serum of patients with serous epithelial ovarian cancer.
    Bondurant AE; Huang Z; Whitaker RS; Simel LR; Berchuck A; Murphy SK
    Gynecol Oncol; 2011 Dec; 123(3):581-7. PubMed ID: 21955482
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Discovery of new methylation markers to improve screening for cervical intraepithelial neoplasia grade 2/3.
    Boers A; Wang R; van Leeuwen RW; Klip HG; de Bock GH; Hollema H; van Criekinge W; de Meyer T; Denil S; van der Zee AGJ; Schuuring E; Wisman GBA
    Clin Epigenetics; 2016; 8():29. PubMed ID: 26962367
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Aberrant methylation of RASSF1A in plasma DNA before breast cancer diagnosis in the Breast Cancer Family Registry.
    Yazici H; Terry MB; Cho YH; Senie RT; Liao Y; Andrulis I; Santella RM
    Cancer Epidemiol Biomarkers Prev; 2009 Oct; 18(10):2723-5. PubMed ID: 19755643
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Diagnostic Capacity of RASSF1A Promoter Methylation as a Biomarker in Tissue, Brushing, and Blood Samples of Nasopharyngeal Carcinoma.
    Ye M; Huang T; Ni C; Yang P; Chen S
    EBioMedicine; 2017 Apr; 18():32-40. PubMed ID: 28396012
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Concentration and Methylation of Cell-Free DNA from Blood Plasma as Diagnostic Markers of Renal Cancer.
    Skrypkina I; Tsyba L; Onyshchenko K; Morderer D; Kashparova O; Nikolaienko O; Panasenko G; Vozianov S; Romanenko A; Rynditch A
    Dis Markers; 2016; 2016():3693096. PubMed ID: 27725787
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Inactivation of RAS association domain family 1A gene in cervical carcinomas and the role of human papillomavirus infection.
    Kuzmin I; Liu L; Dammann R; Geil L; Stanbridge EJ; Wilczynski SP; Lerman MI; Pfeifer GP
    Cancer Res; 2003 Apr; 63(8):1888-93. PubMed ID: 12702579
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Methylation of the hsa-miR-124, SOX1, TERT, and LMX1A genes as biomarkers for precursor lesions in cervical cancer.
    Rogeri CD; Silveira HCS; Causin RL; Villa LL; Stein MD; de Carvalho AC; Arantes LMRB; Scapulatempo-Neto C; Possati-Resende JC; Antoniazzi M; Longatto-Filho A; Fregnani JHTG
    Gynecol Oncol; 2018 Sep; 150(3):545-551. PubMed ID: 29960712
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Assessment of DNA methylation for the detection of cervical neoplasia in liquid-based cytology specimens.
    Kim JH; Choi YD; Lee JS; Lee JH; Nam JH; Choi C
    Gynecol Oncol; 2010 Jan; 116(1):99-104. PubMed ID: 19836067
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Quantitative adenomatous polyposis coli promoter methylation analysis in tumor tissue, serum, and plasma DNA of patients with lung cancer.
    Usadel H; Brabender J; Danenberg KD; Jerónimo C; Harden S; Engles J; Danenberg PV; Yang S; Sidransky D
    Cancer Res; 2002 Jan; 62(2):371-5. PubMed ID: 11809682
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prognostic significance of DAPK and RASSF1A promoter hypermethylation in non-small cell lung cancer (NSCLC).
    Niklinska W; Naumnik W; Sulewska A; Kozłowski M; Pankiewicz W; Milewski R
    Folia Histochem Cytobiol; 2009; 47(2):275-80. PubMed ID: 19926549
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A quantitative promoter methylation profile of prostate cancer.
    Jerónimo C; Henrique R; Hoque MO; Mambo E; Ribeiro FR; Varzim G; Oliveira J; Teixeira MR; Lopes C; Sidransky D
    Clin Cancer Res; 2004 Dec; 10(24):8472-8. PubMed ID: 15623627
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Promoter hypermethylation of the tumor-suppressor genes RASSF1A, GSTP1 and CDH1 in endometrial cancer.
    Fiolka R; Zubor P; Janusicova V; Visnovsky J; Mendelova A; Kajo K; Lasabova Z; Plank L; Danko J
    Oncol Rep; 2013 Dec; 30(6):2878-86. PubMed ID: 24068440
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Analysis of RASSF1A promoter hypermethylation in serum DNA of non-small cell lung cancer].
    Yu ZH; Wang YC; Chen LB; Song Y; Liu C; Xia XY; Lin Q; Ma CY
    Zhonghua Zhong Liu Za Zhi; 2008 Apr; 30(4):284-7. PubMed ID: 18788633
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Methylation of RASSF1A gene promoter and the correlation with DNMT1 expression that may contribute to esophageal squamous cell carcinoma.
    Du Z; Ma K; Sun X; Li A; Wang H; Zhang L; Lin F; Feng X; Song J
    World J Surg Oncol; 2015 Apr; 13():141. PubMed ID: 25886188
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Role of physical activity in modulating breast cancer risk as defined by APC and RASSF1A promoter hypermethylation in nonmalignant breast tissue.
    Coyle YM; Xie XJ; Lewis CM; Bu D; Milchgrub S; Euhus DM
    Cancer Epidemiol Biomarkers Prev; 2007 Feb; 16(2):192-6. PubMed ID: 17301249
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Methylation quantification of adenomatous polyposis coli (APC) gene promoter in plasma of lung cancer patients].
    Pan SY; Xie EF; Shu YQ; Gao L; Zhang LX; Chen D; Chen JB; Zhao WJ; Mu Y; Zhang JN
    Ai Zheng; 2009 Apr; 28(4):384-9. PubMed ID: 19622298
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Ras association domain family 1A: a promising prognostic marker in recurrent nonmuscle invasive bladder cancer.
    Kim JS; Chae Y; Ha YS; Kim IY; Byun SS; Yun SJ; Kim WJ
    Clin Genitourin Cancer; 2012 Jun; 10(2):114-20. PubMed ID: 22382007
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Methylation of the putative tumor suppressor gene, RASSF1A, in primary cervical tumors].
    Maliukova AV; Loginov VI; Khodyrev DS; Kadyrova EL; Pronina IV; Ivanova TA; Kiselev FL; Zabarovskiĭ NP; Braga EA
    Mol Biol (Mosk); 2004; 38(6):1005-13. PubMed ID: 15612586
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.